Professor Sir Munir Pirmohamed
"We undertook research to better understand why serious side effects occur in 7% of HIV patients treated with abacavir. We found that this was due to a genetic factor and developed a test to screen for this which led to a reduction in the incidence of serious side effects to under 1%.”
Prof. Sir Munir Pirmohamed, David Weatherall chair of medicine, NHS chair of pharmacogenetics and head of department of molecular and clinical pharmacology, University of Liverpool and Royal Liverpool University Hospital.
|